Arcutis Biotherapeutics, Inc. (ARQT) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Wed, Nov 4, 2026after close 35 8-K
Q2 FY2026Wed, Aug 5, 2026after close 36 8-K
Q4 FY2025Wed, Feb 25, 2026after close 56 8-K
Q3 FY2025Tue, Oct 28, 2025before open 28 8-K
Q2 FY2025Wed, Aug 6, 2025after close 37 8-K
Q1 FY2025Tue, May 6, 2025after close 36 8-K
Q4 FY2024Tue, Feb 25, 2025after close 56 8-K
Q3 FY2024Wed, Nov 6, 2024after close 37 8-K

What they guided beta

Q3 FY2026 "Raised 2026 full-year net product sales guidance to $535 million–$545 million" exhibit
Q3 FY2026 "Remains on track to disclose topline results from Phase 2 trial of ZORYVE foam 0.3% in individuals with vitiligo and decision on program advancement in Q4 of 2026" exhibit
Q3 FY2026 "The Company remains on track to disclose topline results from the Phase 2 proof-of-concept study of ZORYVE foam 0.3% for the treatment of vitiligo and share its decision on program advancement by the end of 2026." exhibit
Q3 FY2026 "The Company continues to enroll patients in the Phase 2 proof-of-concept studies of ZORYVE foam 0.3% for the treatment of hidradenitis suppurativa, and expects to report results, as well as a decision on program advancement, in the first quarter of 2027. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 | arcutis.com" exhibit
Q3 FY2026 "The Company raised net product sales guidance for the full year 2026 to $535 million–$545 million from $525 million–$540 million. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 | arcutis.com Conference Call and Webcast Arcutis management will host a conference call and webcast today at 4:30 p.m. ET to discuss the financial results for the quarter and provide a business update." exhibit
Q2 FY2026 "Company raising 2026 full-year net product sales guidance to $525 million–$540 million" exhibit
Q2 FY2026 "The Company expects to report results, as well as decisions on program advancement in these indications, in the fourth quarter of 2026 and first quarter of 2027, respectively." exhibit
Q2 FY2026 "Financial Guidance The Company raised net product sales guidance for the full year 2026 from $480 million–$495 million to $525 million–$540 million. 3027 Townsgate Road, Suite 300 Westlake Village, CA 91361 | arcutis.com Conference Call and Webcast Arcutis management will host a conference call and webcast today at 4:30 p.m. ET to discuss the financial results for the quarter and provide a business update." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ARQT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ARQT

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ARQT earnings date badge

HTML

<a href="https://veritasdata.dev/company/ARQT/"><img src="https://veritasdata.dev/embed/ARQT.svg" alt="ARQT earnings date" width="240" height="56"></a>

Markdown

[![ARQT earnings date](https://veritasdata.dev/embed/ARQT.svg)](https://veritasdata.dev/company/ARQT/)

Script

<script async src="https://veritasdata.dev/embed/ARQT.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ARQT"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.